EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,198 | -56.7% | 33,436 | 0.0% | 0.00% | – |
Q2 2023 | $23,539 | -72.6% | 33,436 | -65.1% | 0.00% | – |
Q1 2023 | $85,958 | -35.1% | 95,839 | -14.7% | 0.00% | – |
Q4 2022 | $132,533 | -83.8% | 112,316 | +3.5% | 0.00% | – |
Q3 2022 | $818,000 | +21.9% | 108,528 | +1.9% | 0.00% | – |
Q2 2022 | $671,000 | -9.0% | 106,502 | +20.1% | 0.00% | – |
Q1 2022 | $737,000 | +63.4% | 88,711 | +2.3% | 0.00% | – |
Q4 2021 | $451,000 | -22.2% | 86,758 | 0.0% | 0.00% | – |
Q3 2021 | $580,000 | -18.1% | 86,758 | +4.5% | 0.00% | – |
Q2 2021 | $708,000 | +4.0% | 83,031 | +7.9% | 0.00% | – |
Q1 2021 | $681,000 | -25.3% | 76,931 | +3.7% | 0.00% | – |
Q4 2020 | $912,000 | +66.1% | 74,188 | +10.1% | 0.00% | – |
Q3 2020 | $549,000 | -7.4% | 67,387 | +9.2% | 0.00% | – |
Q2 2020 | $593,000 | +45.3% | 61,701 | +3.0% | 0.00% | – |
Q1 2020 | $408,000 | -55.0% | 59,879 | -1.5% | 0.00% | – |
Q4 2019 | $906,000 | +65.6% | 60,803 | +13.9% | 0.00% | – |
Q3 2019 | $547,000 | -3.4% | 53,360 | 0.0% | 0.00% | – |
Q2 2019 | $566,000 | – | 53,360 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
CAXTON CORP | 116,884 | $970,000 | 1.21% |